<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>For the development of an aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> a large number of causes is taken into consideration </plain></SENT>
<SENT sid="1" pm="."><plain>In our own clinical material of 26 patients in 15 patients none of the up to now known noxae could be established </plain></SENT>
<SENT sid="2" pm="."><plain>Recently in the clarification of the picture of the disease important pathophysiological realizations were got </plain></SENT>
<SENT sid="3" pm="."><plain>In these cases disturbances of the stem cell compartments, effects through the matrix of the haematopoietic cells and immunological processes have been recognized as significant </plain></SENT>
<SENT sid="4" pm="."><plain>--Own investigations concerning the therapy with the anabolic metenolonenanthat (Primobolan-S) yielded approximately the same large number of therapeutic failures and patients with a good result of the treatment or a partial remission in 15 idiopathic and 11 toxically conditioned <z:hpo ids='HP_0001903'>anaemias</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the partial remissions in most cases a <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> continued existing </plain></SENT>
<SENT sid="6" pm="."><plain>A therapy lasting at least two months is necessary in order to estimate the result of the therapy </plain></SENT>
<SENT sid="7" pm="."><plain>At the present time cannot yet be predicted on which conditions the use of anabolics will be successful </plain></SENT>
</text></document>